Catalyst Wire Dossier Catalyst Wire Dossier

Leriglitazone

leriglitazone · Minoryx Therapeutics, S.L.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Leriglitazone, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy [Phase 3]

See pricing